The regulation of the JAK2-STAT3 pathway by Chemerin/CMKLR1 can augment autophagy and ameliorate hepatic oxidative stress, thereby enhancing NASH. The gene discussed is JAK2; the disease is metabolic dysfunction-associated steatohepatitis.